This inventor holds 3 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Arrowhead Pharmaceuticals, Inc., Arrowhead Research Corporation, Novartis Ag. Active years: 2013-2019.
Company Filing History:
1 out of 102 
1 out of 18 
1 out of 3,973 
Years Active: 2013-2019
Title: Mark Aron Labow: Innovator in Viral Infection Treatment
Introduction
Mark Aron Labow is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic solutions for viral infections. With a total of 3 patents, Labow's work focuses on innovative approaches to combat diseases caused by positive stranded RNA viruses.
Latest Patents
One of Labow's latest patents involves the use of double-stranded ribonucleic acids (dsRNAs) for treating viral infections. This invention targets the gene expression of phosphatidylinositol 4-kinase (PI4K), specifically the human phosphatidylinositol 4-kinase, catalytic, beta polypeptide (PIK4CB) and the alpha polypeptide (PIK4CA). The dsRNAs are designed to be less than 30 nucleotides in length, typically ranging from 19 to 25 nucleotides, and are substantially complementary to parts of the target mRNA. The invention also includes a pharmaceutical composition that combines the dsRNA with a pharmaceutically acceptable carrier, utilizing delivery modalities such as fully encapsulated liposomes or lipid complexes. Furthermore, Labow's patent outlines methods for treating diseases caused by positive stranded RNA virus infections and inhibiting their propagation in and between cells.
Career Highlights
Throughout his career, Labow has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Arrowhead Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in developing innovative treatments for viral infections.
Collaborations
Labow has collaborated with notable professionals in his field, including Larry Alexander Gaither and Jason Borawski. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations.
Conclusion
Mark Aron Labow is a distinguished inventor whose work in the field of viral infection treatment showcases his commitment to advancing medical science. His innovative patents and collaborations reflect his significant contributions to biotechnology.